A study on bat genomes, involving Texas Tech University, discovered genetic adaptations that help bats resist viral ...
StockNews.com initiated coverage on shares of RedHill Biopharma (NASDAQ:RDHL – Get Free Report) in a research note issued to investors on Sunday. The firm set a “hold” rating on the biotechnology ...
The SARS-CoV-2 pandemic interrupted much respiratory research. Respiratory clinical academics joined colleagues in providing clinical care, and global research efforts were directed to finding new ...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with more rapid progression of coronary ...
Leukocyte count is an independent predictor of future postacute sequelae of severe acute respiratory coronavirus 2 infection (PASC) in postmenopausal women.
Researchers found that COVID-19 may accelerate biological processes linked to Alzheimer’s, showing changes in brain-related ...
Chip Chick on MSN2d
Bats Don't Get Sick, Despite Being Disease Carriers, And Scientists Now Understand Why This IsMany viruses have been linked to bats, as they are known disease carriers. The Ebola, Marburg, Nipah, and Hendra viruses […] ...
Techno-Science on MSN3d
Covid-19: in hindsight, which countries responded best during the pandemic? 😷By Arnaud Fontanet - Physician, Director of the Epidemiology of Emerging Diseases Unit at the Institut Pasteur, Professor of ...
It's an unusual winter for respiratory illnesses. The flu is peaking twice: once in early January and again in February.
The study revealed that a gene common in some bats can reduce the production of the SARS-CoV-2 virus by up to 90%, which could help lead to new medical approaches to combating viral diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback